0000899243-20-003809.txt : 20200210 0000899243-20-003809.hdr.sgml : 20200210 20200210161323 ACCESSION NUMBER: 0000899243-20-003809 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200210 DATE AS OF CHANGE: 20200210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynton Michael CENTRAL INDEX KEY: 0001606115 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 20592049 MAIL ADDRESS: STREET 1: 2000 AVENUE OF THE STARS 12TH FL CITY: LOS ANGELES STATE: CA ZIP: 90067 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 120 WEST 45TH STREET STREET 2: 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-10 0 0001490978 Schrodinger, Inc. SDGR 0001606115 Lynton Michael C/O SCHRODINGER, INC., 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036 1 0 0 0 Stock Option (right to buy) 17.00 2020-02-10 4 A 0 12909 0.00 A 2030-02-04 Common Stock 12909 12909 D The option was granted on February 5, 2020. The commencement of vesting was contingent upon the closing of the Issuer's initial public offering, which occurred on February 10, 2020. The shares underlying the option are scheduled to vest in full on February 5, 2021. /s/ Yvonne Tran, as attorney-in-fact for Michael Lynton 2020-02-10